http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104478997-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
filingDate 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104478997-B
titleOfInvention A kind of synthetic method of fullerene cyclic peptide
abstract The invention discloses a kind of fullerene cyclic peptide and its synthetic methods, and the cyclic peptide with protecting group is dissolved in DMF, when adding in succinic anhydride and small N methylmorphine woodss normal-temperature reaction 0.2 ~ 5, are then extracted;The product being obtained by extraction is dissolved in fullerene list addition pyrrolidines in DCM and DMF mixed liquors, when then addition DCC, HOBT and DMAP normal-temperature reaction 20 ~ 100 is small, carries out column chromatography;The product that column chromatography obtains is dissolved in TFA/DCM mixed liquors, when normal-temperature reaction 1 ~ 6 is small, then adds in ice ether, 4 DEG C overnight, and yellowish color substance is precipitated, and target product is obtained after dry.The fullerene cyclic peptide that the present invention obtains can promote the stability of polypeptide in vivo, and with good active anticancer;Cyclic peptide has stronger acceptor binding force and receptor-specific than corresponding linear peptides, has the efficient targeting to cancer cell and the efficient characteristic for removing free radical, is good antioxidant.
priorityDate 2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485223053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135399369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416172369
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550086
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448103735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21426946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540587
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388

Total number of triples: 44.